U.S. pharma huge copyright scrapped two experimental weight loss pills final yr—a when-day by day capsule, lotiglipron, because of elevated liver enzymes and a 2 times-everyday tablet, danuglipron, as a result of sturdy Negative effects—but CEO Albert Bourla has reported the company